Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$431,830
+$172,881 QoQ
Shares Held
3,418
+84.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,450
of 2,266 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FourThought Financial Partners, LLC holds $48,924,367 across 10 Drug Manufacturers - General names. GILD ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
80,917 | $15,343,481 | |
| 2 | AMGN |
Amgen Inc
|
32,361 | $11,718,565 | |
| 3 | LLY |
ELI LILLY & Co
|
5,899 | $7,075,438 | |
| 4 | NVO |
Novo Nordisk A S
|
102,109 | $4,895,105 | |
| 5 | ABBV |
AbbVie Inc.
|
17,032 | $4,285,932 | |
| 6 | JNJ |
Johnson & Johnson
|
14,967 | $3,801,168 | |
| 7 | MRK |
Merck & Co., Inc.
|
4,550 | $584,675 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
3,418 | $431,830 |
All Filings in GILD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $431,830 | 3,418 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $258,949 | 1,858 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||